Dynex Capital swings to $336M loss in Q3 2026
Wider Agency MBS spreads pressured book value despite partial offsets from interest-rate hedge gains.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Dynex Capital, Inc. (DX) reported a third-quarter 2026 net loss of $335.536 million, versus net income of $150.388 million a year earlier. Net interest income was $101.562 million, compared with $30.611 million. Wider Agency mortgage-backed securities spreads drove a decline in portfolio fair value and book value; interest-rate hedge gains offset part of the impact. Total economic return was (11.5)%. Book value per common share was $10.91 at September 30, down from $12.90 at June 30; the quarter included $0.51 of declared common dividends per share.
Dynex grew its capital base by $384 million in the quarter through common and preferred equity raises, using net proceeds to add $3.2 billion of Agency mortgage-backed securities. The investment portfolio increased approximately 3% to $28.3 billion from $27.6 billion at June 30. Repurchase agreement borrowings were $24 billion as of September 30, 2026, versus $14 billion as of December 31, 2025; leverage, including the implied cost of TBAs, increased to 9.0 times shareholders’ equity.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointThird-quarter net interest income reached $101.562 million, versus $30.611 million in 2025.
Negative
- Major pointThird-quarter net loss was $335.536 million, versus $150.388 million net income in 2025.
- Major pointThird-quarter economic return was (11.5)%, and book value fell to $10.91 per share.
Filing Explained
Series D shares carry cumulative quarterly dividends at 9.375% of $25 per share beginning January 15, 2027.
The 10-Q reports that Dynex issued 83,119,388 common shares through its at-the-market program during the first nine months of 2026 for
Separately, Dynex sold 4,800,000 Series D preferred shares during the quarter and received
Key Figures
Key Terms
TBA dollar roll transactions financial
drop income (loss) financial
fair value option financial
SOFR-based interest rate swaps technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was DX’s net loss in the third quarter of 2026?
What were DX’s Series D preferred stock terms?
How many common shares did DX issue through its ATM program?
AI-generated analysis. How Rhea-AI works. Not financial advice.
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||
(Address of principal executive offices) | (Zip Code) | |||||
(Registrant’s telephone number, including area code) | ||||||
Securities registered pursuant to Section 12(b) of the Act: | ||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
6.900% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, par value $0.01 per share | ||||
9.375% Series D Fixed-Rate Cumulative Redeemable Preferred Stock, par value $0.01 per share | ||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. | ||||
☒ | No | ☐ | ||
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). | ||||
☒ | No | ☐ | ||
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. | ||||
☒ | Accelerated filer | ☐ | ||
Non-accelerated filer | ☐ | Smaller reporting company | ||
Emerging growth company | ||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ | ||||
Page | |||
PART I. FINANCIAL INFORMATION | |||
Item 1. | Financial Statements | ||
Consolidated Balance Sheets as of September 30, 2026 (unaudited) and December 31, 2025 | 1 | ||
Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2026 (unaudited) and September 30, 2025 (unaudited) | 2 | ||
Consolidated Statements of Shareholders' Equity for the three and nine months ended September 30, 2026 (unaudited) and September 30, 2025 (unaudited) | 3 | ||
Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 (unaudited) and September 30, 2025 (unaudited) | 5 | ||
Notes to the Consolidated Financial Statements (unaudited) | 7 | ||
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 25 | |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 45 | |
Item 4. | Controls and Procedures | 48 | |
PART II. OTHER INFORMATION | |||
Item 1. | Legal Proceedings | 48 | |
Item 1A. | Risk Factors | 48 | |
Item 2. | Unregistered Sales of Equity and Use of Proceeds | 48 | |
Item 3. | Defaults Upon Senior Securities | 49 | |
Item 4. | Mine Safety Disclosures | 49 | |
Item 5. | Other Information | 49 | |
Item 6. | Exhibits | 49 | |
SIGNATURES | 51 | ||
September 30, 2026 | December 31, 2025 | ||
ASSETS | (unaudited) | ||
Cash and cash equivalents | $ | $ | |
Cash collateral posted to counterparties | |||
Mortgage-backed securities (including pledged assets of $ $ | |||
Due from counterparties | |||
Derivative assets | |||
Accrued interest receivable | |||
Other assets | |||
Total assets | $ | $ | |
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
Liabilities: | |||
Repurchase agreements | $ | $ | |
Due to counterparties | |||
Derivative liabilities | |||
Cash collateral posted by counterparties | |||
Accrued interest payable | |||
Dividends payable | |||
Other liabilities | |||
Total liabilities | |||
Shareholders’ equity: | |||
Preferred stock, par value $ ($ | |||
Common stock, par value $ shares authorized, respectively; issued and outstanding, respectively | |||
Additional paid-in capital | |||
Accumulated other comprehensive loss | ( | ( | |
Accumulated deficit | ( | ( | |
Total shareholders’ equity | |||
Total liabilities and shareholders’ equity | $ | $ |
Three Months Ended | Nine Months Ended | ||||||
September 30, | September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
INTEREST INCOME | |||||||
Interest income | $ | $ | $ | $ | |||
Interest expense | ( | ( | ( | ( | |||
Net interest income | |||||||
GAINS (LOSSES) | |||||||
Realized (loss) gain on sales of investments, net | ( | ||||||
Unrealized (loss) gain on investments, net | ( | ( | |||||
Gain (loss) on derivative instruments, net | ( | ( | |||||
Total (losses) gains, net | ( | ( | |||||
EXPENSES | |||||||
Compensation and benefits | ( | ( | ( | ( | |||
Other general and administrative | ( | ( | ( | ( | |||
Other operating expenses | ( | ( | ( | ( | |||
Total operating expenses | ( | ( | ( | ( | |||
Net (loss) income | $( | $ | $( | $ | |||
Preferred stock dividends | ( | ( | ( | ( | |||
Net (loss) income to common shareholders | $( | $ | $( | $ | |||
Other comprehensive income: | |||||||
Unrealized (loss) gain on available-for-sale investments | $( | $ | $( | $ | |||
Total other comprehensive (loss) income | ( | ( | |||||
Comprehensive (loss) income to common shareholders | $( | $ | $( | $ | |||
Weighted average common shares-basic | |||||||
Weighted average common shares-diluted | |||||||
Net (loss) income per common share-basic | $( | $ | $( | $ | |||
Net (loss) income per common share-diluted | $( | $ | $( | $ | |||
For the Three and Nine Months Ended September 30, 2026 | |||||||||||||
Preferred Stock | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Loss | Accumulated Deficit | Total Shareholders’ Equity | ||||||||
Shares | Amount | Shares | Amount | ||||||||||
Balance as of June 30, 2026 | $ | $ | $ | $( | $( | $ | |||||||
Stock issuance | — | — | |||||||||||
Share-based compensation, net of amortization | — | — | ( | — | — | ( | |||||||
Adjustments for tax withholding on share- based compensation | — | — | ( | ( | ( | — | — | ( | |||||
Stock issuance costs | — | — | — | — | ( | — | — | ( | |||||
Net loss | — | — | — | — | — | — | ( | ( | |||||
Dividends on preferred stock | — | — | — | — | — | — | ( | ( | |||||
Dividends on common stock | — | — | — | — | — | — | ( | ( | |||||
Other comprehensive loss | — | — | — | — | — | ( | — | ( | |||||
Balance as of September 30, 2026 | $ | $ | $ | $( | $( | $ | |||||||
Balance as of December 31, 2025 | $ | $ | $ | $( | $( | $ | |||||||
Stock issuance | — | — | |||||||||||
Share-based compensation, net of amortization | — | — | — | — | |||||||||
Adjustments for tax withholding on share- based compensation | — | — | ( | ( | ( | — | — | ( | |||||
Stock issuance costs | — | — | — | — | ( | — | — | ( | |||||
Net loss | — | — | — | — | — | — | ( | ( | |||||
Dividends on preferred stock | — | — | — | — | — | — | ( | ( | |||||
Dividends on common stock | — | — | — | — | — | — | ( | ( | |||||
Other comprehensive loss | — | — | — | — | — | ( | — | ( | |||||
Balance as of September 30, 2026 | $ | $ | $ | $( | $( | $ | |||||||
For the Three and Nine Months Ended September 30, 2025 | |||||||||||||
Preferred Stock | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Loss | Accumulated Deficit | Total Shareholders’ Equity | ||||||||
Shares | Amount | Shares | Amount | ||||||||||
Balance as of June 30, 2025 | $ | $ | $ | $( | $( | $ | |||||||
Stock issuance | — | — | — | — | |||||||||
Share-based compensation, net of amortization | — | — | — | — | |||||||||
Adjustments for tax withholding on share- based compensation | — | — | ( | — | ( | — | — | ( | |||||
Stock issuance costs | — | — | — | — | ( | — | — | ( | |||||
Net income | — | — | — | — | — | — | |||||||
Dividends on preferred stock | — | — | — | — | — | — | ( | ( | |||||
Dividends on common stock | — | — | — | — | — | — | ( | ( | |||||
Other comprehensive income | — | — | — | — | — | — | |||||||
Balance as of September 30, 2025 | $ | $ | $ | $( | $( | $ | |||||||
Balance as of December 31, 2024 | $ | $ | $ | $( | $( | $ | |||||||
Stock issuance | — | — | — | — | |||||||||
Share-based compensation, net of amortization | — | — | — | — | |||||||||
Adjustments for tax withholding on share- based compensation | — | — | ( | ( | ( | — | — | ( | |||||
Stock issuance costs | — | — | — | — | ( | — | — | ( | |||||
Net income | — | — | — | — | — | — | |||||||
Dividends on preferred stock | — | — | — | — | — | — | ( | ( | |||||
Dividends on common stock | — | — | — | — | — | — | ( | ( | |||||
Other comprehensive income | — | — | — | — | — | — | |||||||
Balance as of September 30, 2025 | $ | $ | $ | $( | $( | $ | |||||||
Nine Months Ended | |||
September 30, | |||
2026 | 2025 | ||
Operating activities: | |||
Net (loss) income | $( | $ | |
Adjustments to reconcile net income (loss) to cash provided by operating activities: | |||
Realized gain on sales of investments, net | ( | ||
Unrealized loss (gain) on investments, net | ( | ||
(Gain) loss on derivative instruments, net | ( | ||
Amortization of investment premiums, net | |||
Other amortization and depreciation | |||
Share-based compensation expense | |||
Increase in accrued interest receivable | ( | ( | |
Increase in accrued interest payable | |||
Change in other assets and liabilities, net | ( | ( | |
Net cash provided by operating activities | |||
Investing activities: | |||
Purchases of mortgage-backed securities | ( | ( | |
Principal payments received on mortgage-backed securities, fair value option | |||
Principal payments received on mortgage-backed securities, available-for-sale | |||
Proceeds from sales of mortgage-backed securities | |||
Principal payments received on mortgage loans held for investment | |||
Net receipts (payments) on derivative instruments | ( | ||
(Decrease) increase in cash collateral posted by counterparties | ( | ||
Net cash used in investing activities | ( | ( | |
Financing activities: | |||
Borrowings under repurchase agreements | |||
Repayments of repurchase agreement borrowings | ( | ( | |
Proceeds from issuance of preferred stock | |||
Proceeds from issuance of common stock | |||
Cash paid for stock issuance costs | ( | ( | |
Payments related to tax withholding for share-based compensation | ( | ( | |
Dividends paid | ( | ( | |
Net cash provided by financing activities | |||
Net increase in cash, including cash posted to counterparties | |||
Cash including cash collateral posted to counterparties at beginning of period | |||
Cash including cash collateral posted to counterparties at end of period | $ | $ | |
Supplemental Disclosure of Cash Activity: | |||
Cash paid for interest on repurchase agreements | $ | $ | |
Noncash Investing Activities: | |||
Payable for investments pending settlement | $ | $ |
($s in thousands) | September 30, 2026 |
Cash and cash equivalents | $ |
Cash collateral posted to counterparties | |
Total cash including cash posted to counterparties shown on consolidated statement of cash flows | $ |
Three Months Ended | Nine Months Ended | ||||||
September 30, | September 30, | ||||||
($s in thousands) | 2026 | 2025 | 2026 | 2025 | |||
Weighted average number of common shares outstanding - basic | |||||||
Incremental common shares-unvested RSUs | |||||||
Incremental common shares-unvested PSUs | |||||||
Weighted average number of common shares outstanding - diluted | |||||||
Net (loss) income to common shareholders | $( | $ | $( | $ | |||
Net (loss) income per common share-basic | $( | $ | $( | $ | |||
Net (loss) income per common share-diluted | $( | $ | $( | $ | |||
September 30, 2026 | |||||||
($s in thousands) | Agency RMBS | Agency CMBS | CMBS IO (1) | Total | |||
Measured at fair value through net income: | |||||||
Amortized cost | $ | $ | $ | $ | |||
Gross unrealized gain | |||||||
Gross unrealized loss | ( | ( | ( | ( | |||
Fair value through net income | $ | $ | $ | $ | |||
Measured at fair value through OCI: | |||||||
Amortized cost | $ | $ | $ | $ | |||
Gross unrealized gain | |||||||
Gross unrealized loss | ( | ( | ( | ( | |||
Fair value through OCI | $ | $ | $ | $ | |||
Total | $ | $ | $ | $ | |||
December 31, 2025 | |||||||
Agency RMBS | Agency CMBS | CMBS IO (1) | Total | ||||
Measured at fair value through net income: | |||||||
Amortized cost | $ | $ | $ | $ | |||
Gross unrealized gain | |||||||
Gross unrealized loss | ( | ( | ( | ( | |||
Fair value through net income | $ | $ | $ | $ | |||
Measured at fair value through OCI: | |||||||
Amortized cost | $ | $ | $ | $ | |||
Gross unrealized gain | |||||||
Gross unrealized loss | ( | ( | ( | ( | |||
Fair value through OCI | $ | $ | $ | $ | |||
Total | $ | $ | $ | $ | |||
(1) The Company held a notional balance of CMBS IO of $ of December 31, 2025. | |||||||
Three Months Ended | Nine Months Ended | ||||||
September 30, | September 30, | ||||||
($s in thousands) | 2026 | 2025 | 2026 | 2025 | |||
Agency RMBS | $( | $ | $( | $ | |||
Agency CMBS | ( | ( | |||||
CMBS IO | ( | ( | |||||
Other investments | ( | ( | ( | ||||
Unrealized (loss) gain on investments, net | $( | $ | $( | $ | |||
Three Months Ended | Nine Months Ended | ||||||
September 30, | September 30, | ||||||
($s in thousands) | 2026 | 2025 | 2026 | 2025 | |||
Realized gain on sales of MBS - FVO | $ | $ | $ | $ | |||
Realized loss on sale of MBS - FVO | ( | ( | |||||
Total realized (loss) gain on sales of investments, net | $( | $ | $ | $ | |||
September 30, 2026 | December 31, 2025 | |||||||||||
($s in thousands) | Fair Value | Gross Unrealized Losses | # of Securities | Fair Value | Gross Unrealized Losses | # of Securities | ||||||
Continuous unrealized loss position for less than 12 months: | ||||||||||||
Agency MBS | $ | $( | $ | $( | ||||||||
Non-Agency MBS | ( | ( | ||||||||||
Continuous unrealized loss position for 12 months or longer: | ||||||||||||
Agency MBS | $ | $( | $ | $( | ||||||||
Non-Agency MBS | ( | |||||||||||
September 30, 2026 | December 31, 2025 | |||||||||||
Collateral Type | Balance | Weighted Average Rate | Fair Value of Collateral Pledged (1) | Balance | Weighted Average Rate | Fair Value of Collateral Pledged (1) | ||||||
($s in thousands) | ||||||||||||
Agency RMBS | $ | $ | $ | $ | ||||||||
Agency CMBS | ||||||||||||
Agency CMBS IO | ||||||||||||
Non-Agency CMBS IO | ||||||||||||
Total | $ | $ | $ | $ | ||||||||
September 30, 2026 | December 31, 2025 | |||||||||||
Remaining Term to Maturity | Balance | Weighted Average Rate | WAVG Original Term to Maturity | Balance | Weighted Average Rate | WAVG Original Term to Maturity | ||||||
($s in thousands) | ||||||||||||
Less than 30 days | $ | $ | ||||||||||
30 to 90 days | ||||||||||||
91 to 180 days | ||||||||||||
Total | $ | $ | ||||||||||
($s in thousands) | Gross Amount of Recognized Liabilities | Gross Amount Offset in the Balance Sheet | Net Amount of Liabilities Presented in the Balance Sheet | Gross Amount Not Offset in the Balance Sheet (1) | Net Amount | ||||||
Financial Instruments Posted as Collateral | Cash Posted as Collateral | ||||||||||
September 30, 2026: | |||||||||||
Repurchase agreements | $ | $ | $ | $( | $ | $ | |||||
December 31, 2025: | |||||||||||
Repurchase agreements | $ | $ | $ | $( | $ | $ | |||||
Three Months Ended | Nine Months Ended | |||||||
September 30, | September 30, | |||||||
Type of Derivative Instrument | 2026 | 2025 | 2026 | 2025 | ||||
($s in thousands) | ||||||||
U.S. Treasury futures | $ | $( | $ | $( | ||||
Interest rate swaps | ( | ( | ||||||
Interest rate swaptions | ( | ( | ( | ( | ||||
Options on U.S. Treasury futures | ( | ( | ( | |||||
TBA securities | ( | ( | ||||||
Gain (loss) on derivative instruments, net | $ | $( | $ | $( | ||||
Type of Derivative Instrument | Balance Sheet Location | Purpose | September 30, 2026 | December 31, 2025 | ||||
($s in thousands) | ||||||||
Options on U.S. Treasury futures | Derivative assets | Economic hedging | $ | $ | ||||
TBA securities | Derivative assets | Investing | ||||||
Total derivatives assets | $ | $ | ||||||
Interest rate swaptions | Derivative liabilities | Economic hedging | $ | $ | ||||
TBA securities | Derivative liabilities | Investing | ||||||
Total derivatives liabilities | $ | $ | ||||||
September 30, 2026 | December 31, 2025 | |||||||
Pay Fixed Interest Rate Swaps - Years to Maturity | Notional Amount | Weighted Average Pay Fixed Rate | Notional Amount | Weighted Average Pay Fixed Rate | ||||
($s in thousands) | ||||||||
1-3 years | $ | $ | ||||||
3-5 years | ||||||||
5-7 years | ||||||||
7-10 years | ||||||||
10-15 years | ||||||||
15-20 years | ||||||||
$ | $ | |||||||
U.S. Treasury Futures | September 30, 2026 | December 31, 2025 | ||
($s in thousands) | ||||
5-year U.S. Treasury futures | $( | $( | ||
10-year U.S. Treasury futures | ( | ( | ||
30-year U.S. Treasury futures | ( | ( | ||
$( | $( |
Option | Underlying Financial Instrument | ||||||||||
($s in thousands) | Cost (1) | Fair Value | Carrying Value (1) | Notional Amount | Average Fixed Receive Rate | Type of Instrument | |||||
As of September 30, 2026: | |||||||||||
Interest rate swaptions | $ | $ | $( | $ | 5 year SOFR- based swap | ||||||
Options on U.S. Treasury futures | n/a | 10-year U.S. Treasury future | |||||||||
As of December 31, 2025: | |||||||||||
Interest rate swaptions | $ | $ | $( | $ | 5 year SOFR- based swap | ||||||
Options on U.S. Treasury futures | n/a | 10-year U.S. Treasury future | |||||||||
TBA securities | September 30, 2026 | December 31, 2025 | ||
($s in thousands) | ||||
Implied market value (1) | $ | $ | ||
Implied cost basis (2) | ||||
Net carrying value (3) | $( | $ |
Type of Derivative Instrument | Beginning Notional Amount | Additions | Settlements, Terminations, or Pair-Offs | Ending Notional Amount | ||||
($s in thousands) | ||||||||
Short positions: | ||||||||
U.S. Treasury futures | $( | $( | $ | $( | ||||
Pay-fixed interest rate swaps | ( | |||||||
Long positions: | ||||||||
Interest rate swaptions | — | |||||||
Options on U.S. Treasury futures | ( | |||||||
TBA securities | ( |
Offsetting of Assets | |||||||||||
($s in thousands) | Gross Amount of Recognized Assets | Gross Amount Offset in the Balance Sheet | Net Amount of Assets Presented in the Balance Sheet | Gross Amount Not Offset in the Balance Sheet (1) | Net Amount | ||||||
Financial Instruments Received as Collateral | Cash Received as Collateral | ||||||||||
September 30, 2026 | |||||||||||
Options on U.S. Treasury futures | $— | $ | $ | $ | $ | $ | |||||
TBA securities | |||||||||||
Derivative assets | $ | $ | $ | $ | $ | $ | |||||
December 31, 2025 | |||||||||||
Options on U.S. Treasury futures | $ | $ | $ | $ | $ | $ | |||||
TBA securities | ( | ( | |||||||||
Derivative assets | $ | $ | $ | $( | $( | $ | |||||
Offsetting of Liabilities | |||||||||||
($s in thousands) | Gross Amount of Recognized Liabilities | Gross Amount Offset in the Balance Sheet | Net Amount of Liabilities Presented in the Balance Sheet | Gross Amount Not Offset in the Balance Sheet (1) | Net Amount | ||||||
Financial Instruments Posted as Collateral | Cash Posted as Collateral | ||||||||||
September 30, 2026 | |||||||||||
Interest rate swaptions | $ | $ | $ | $ | $ | $ | |||||
TBA securities | ( | ||||||||||
Derivative liabilities | $ | $ | $ | $ | $( | $ | |||||
December 31, 2025 | |||||||||||
Interest rate swaptions | $ | $ | $ | $ | $ | $ | |||||
TBA securities | ( | ( | |||||||||
Derivative liabilities | $ | $ | $ | $( | $( | $ | |||||
($s in thousands) | September 30, 2026 | December 31, 2025 | |||||||||||||
Total | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | ||||||||
Assets: | |||||||||||||||
MBS | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
TBA securities (1) | |||||||||||||||
Option on U.S. Treasury futures | |||||||||||||||
Mortgage loans (2) | |||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Liabilities: | |||||||||||||||
TBA securities (1) | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Interest rate swaptions (3) | |||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Nine Months Ended | ||||||||
September 30, | ||||||||
2026 | 2025 | |||||||
Type of Award | Shares | Weighted Average Grant Date Fair Value Per Share | Shares | Weighted Average Grant Date Fair Value Per Share | ||||
Restricted stock: | ||||||||
Awards outstanding, beginning of period | $ | $ | ||||||
Granted | ||||||||
Vested | ( | ( | ||||||
Awards outstanding, end of period | $ | $ | ||||||
Target RSUs: (1) | ||||||||
Awards outstanding, beginning of period | $ | $ | ||||||
Granted | ||||||||
Vested | ( | ( | ||||||
Awards outstanding, end of period | $ | $ | ||||||
Target PSUs: (2) | ||||||||
Awards outstanding, beginning of period | $ | $ | ||||||
Granted | ||||||||
Vested | ( | |||||||
Forfeited | ( | |||||||
Awards outstanding, end of period | $ | $ | ||||||
September 30, 2026 | |||
($s in thousands) | Remaining Compensation Cost | WAVG Period of Recognition | |
Restricted stock | $ | ||
RSUs | |||
PSUs | |||
Total | $ | ||
Dividends Payable | September 30, 2026 | December 31, 2025 | ||
($s in thousands) | ||||
RSU DERs | $ | $ | ||
PSU DERs | ||||
Accrued DERs | ||||
Common stock dividends | $ | $ | ||
Preferred stock dividends | ||||
Accrued dividends | ||||
Total dividends payable | $ | $ |


Market Spreads as of: | Change in Spreads 3Q26 | Change in Spreads YTD | ||||||||||
Investment Type: (1) | September 30, 2026 | June 30, 2026 | March 31, 2026 | December 31, 2025 | ||||||||
Agency RMBS: | ||||||||||||
2.0% coupon | 75 | 72 | 73 | 70 | 3 | 5 | ||||||
2.5% coupon | 73 | 72 | 76 | 73 | 1 | — | ||||||
4.0% coupon | 61 | 52 | 52 | 50 | 9 | 11 | ||||||
4.5% coupon | 60 | 46 | 53 | 45 | 14 | 15 | ||||||
5.0% coupon | 62 | 48 | 56 | 46 | 14 | 16 | ||||||
5.5% coupon | 62 | 51 | 63 | 51 | 11 | 11 | ||||||
6.0% coupon | 68 | 47 | 64 | 54 | 21 | 14 | ||||||
Agency CMBS(2) | 76 | 75 | 84 | 82 | 1 | (6) | ||||||
($s in thousands except per share data) | Net Change in Fair Value | Components of Comprehensive Income | Common Book Value Rollforward | Per Common Share | |||
Balance as of June 30, 2026 (1) | $3,063,567 | $12.90 | |||||
Net interest income | $101,562 | ||||||
Periodic interest from interest rate swaps | 82 | ||||||
G & A and other operating expenses | (12,594) | ||||||
Preferred stock dividends | (2,769) | ||||||
Changes in fair value: | |||||||
MBS and other | $(1,502,120) | ||||||
TBAs | (124,902) | ||||||
U.S. Treasury futures | 377,310 | ||||||
Options on U.S. Treasury futures | 743 | ||||||
Interest rate swaps | 790,435 | ||||||
Interest rate swaptions | (2,581) | ||||||
Total net change in fair value | (461,115) | ||||||
Comprehensive loss to common shareholders | (374,834) | ||||||
Capital transactions: | |||||||
Net proceeds from stock issuance (2) | 260,984 | ||||||
Common dividends declared | (129,162) | ||||||
Balance as of September 30, 2026 (3) | $2,820,555 | $10.91 |




September 30, 2026 | ||||||||||||||
Agency RMBS by Coupon | Par/ Notional | Amortized Cost/ Implied Cost Basis (3)(5) | Fair Value (4)(5) | Weighted Average | ||||||||||
Loan Age (in months)(6) | 3 Month CPR (6)(7) | Estimated Duration (8) | Market Yield (9) | |||||||||||
($s in thousands) | ||||||||||||||
2.0% | $1,622,450 | $1,439,531 | $1,226,468 | 73 | 4.9% | 7.12 | 5.84% | |||||||
2.5% | 837,916 | 801,131 | 664,386 | 72 | 6.5% | 6.84 | 5.86% | |||||||
4.0% | 1,580,885 | 1,483,955 | 1,391,677 | 53 | 7.9% | 6.44 | 5.93% | |||||||
4.5% (1) | 2,508,989 | 2,426,164 | 2,273,108 | 32 | 8.1% | 6.21 | 6.03% | |||||||
5.0% | 8,021,402 | 7,973,568 | 7,468,785 | 18 | 6.1% | 6.03 | 6.08% | |||||||
5.5% | 10,057,691 | 10,162,745 | 9,647,047 | 16 | 6.8% | 5.39 | 6.16% | |||||||
6.0% | 1,769,036 | 1,812,455 | 1,743,004 | 12 | 8.9% | 4.75 | 6.25% | |||||||
TBA 4.0% | 6,000 | 5,386 | 5,224 | n/a | n/a | 7.16 | 5.83% | |||||||
TBA 4.5% | 241,000 | 225,881 | 216,166 | n/a | n/a | 6.95 | 5.93% | |||||||
TBA 5.0% | 1,073,000 | 1,021,997 | 992,031 | n/a | n/a | 6.42 | 6.08% | |||||||
TBA 5.5% | 515,000 | 508,784 | 490,698 | n/a | n/a | 5.58 | 6.22% | |||||||
TBA 6.0% | 728,000 | 733,328 | 713,156 | n/a | n/a | 4.69 | 6.34% | |||||||
Total | $28,961,369 | $28,594,925 | $26,831,750 | 25 | 6.8% | 5.83 | 6.09% | |||||||
December 31, 2025 | ||||||||||||||
Agency RMBS by Coupon | Par/ Notional | Amortized Cost/ Implied Cost Basis (3)(5) | Fair Value (4)(5) | Weighted Average | ||||||||||
Loan Age (in months)(6) | 3 Month CPR (6)(7) | Estimated Duration (8) | Market Yield (9) | |||||||||||
($s in thousands) | ||||||||||||||
2.0% | $603,965 | $613,475 | $497,097 | 63 | 5.2% | 7.42 | 4.68% | |||||||
2.5% | 516,325 | 535,039 | 444,904 | 64 | 5.1% | 7.02 | 4.67% | |||||||
4.0% | 293,073 | 293,432 | 281,889 | 57 | 6.5% | 5.89 | 4.63% | |||||||
4.5% (1) | 1,911,130 | 1,853,757 | 1,881,304 | 33 | 5.8% | 5.46 | 4.74% | |||||||
5.0% | 3,974,655 | 3,913,622 | 3,997,537 | 21 | 5.9% | 4.62 | 4.91% | |||||||
5.5% | 6,325,638 | 6,361,758 | 6,465,769 | 13 | 8.1% | 3.39 | 5.10% | |||||||
6.0% | 1,381,567 | 1,419,727 | 1,432,860 | 9 | 8.2% | 2.28 | 5.14% | |||||||
TBA 4.0% | 1,162,000 | 1,101,441 | 1,102,764 | n/a | n/a | 6.29 | 4.76% | |||||||
TBA 4.5%(2) | 1,447,000 | 1,425,945 | 1,430,136 | n/a | n/a | 4.58 | 4.64% | |||||||
TBA 5.0% | 176,000 | 175,287 | 175,670 | n/a | n/a | 4.51 | 5.03% | |||||||
TBA 5.5% | 183,000 | 185,175 | 185,631 | n/a | n/a | 3.28 | 5.23% | |||||||
TBA 6.0% | 221,000 | 226,218 | 226,922 | n/a | n/a | 1.99 | 5.24% | |||||||
Total | $18,195,353 | $18,104,876 | $18,122,483 | 21 | 7.0% | 4.29 | 4.94% | |||||||
Three Months Ended | |||
$s in thousands | September 30, 2026 | June 30, 2026 | |
Net interest income | $101,562 | $93,783 | |
Realized gain on sales of investments, net | (544) | — | |
Unrealized loss on investments, net | (1,465,047) | (25,622) | |
Gain on derivative instruments, net | 1,041,087 | 128,845 | |
Operating expenses, net | (12,594) | (16,213) | |
Preferred stock dividends | (2,769) | (2,650) | |
Net (loss) income to common shareholders | (338,305) | 178,143 | |
Other comprehensive loss | (36,529) | (865) | |
Comprehensive (loss) income to common shareholders | $(374,834) | $177,278 |
Three Months Ended | |||||||||||
September 30, 2026 | June 30, 2026 | ||||||||||
($s in thousands) | Interest Income/ Expense | Average Balance (1)(2) | Effective Yield/ Financing Cost (3)(4) | Interest Income/ Expense | Average Balance (1)(2) | Effective Yield/ Financing Cost (3)(4) | |||||
Agency RMBS | $311,244 | $24,761,556 | 5.03% | $280,970 | $22,581,412 | 4.98% | |||||
Agency CMBS/ CMBS IO (5) | 16,958 | 1,456,850 | 4.55% | 15,270 | 1,333,481 | 4.52% | |||||
Other investments | 5 | 431 | 3.71% | 6 | 445 | 3.89% | |||||
Subtotal | $328,207 | $26,218,837 | 5.00% | $296,246 | $23,915,338 | 4.95% | |||||
Cash equivalents | 4,290 | 6,505 | |||||||||
Total interest income | $332,497 | $302,751 | |||||||||
Repurchase agreement financing | (230,935) | 23,626,939 | (3.82)% | (208,968) | 21,803,737 | (3.79)% | |||||
Net interest income (expense)/spread | $101,562 | 1.18% | $93,783 | 1.16% | |||||||
Net periodic interest (6) | 82 | —% | 542 | 0.01% | |||||||
Economic net interest income (expense)/ spread (6) | $101,644 | 1.18% | $94,325 | 1.17% | |||||||
*Table Note: Data may not foot due to rounding. | |||||||||||
Three Months Ended | ||||||||
September 30, 2026 | ||||||||
($s in thousands) | Realized Gain (Loss) Recognized in Net Income | Unrealized Gain (Loss) Recognized in Net Income | Unrealized Gain (Loss) Recognized in OCI | Total Change in Fair Value | ||||
Investment portfolio: | ||||||||
Agency RMBS | $(544) | $(1,397,829) | $(34,948) | $(1,433,321) | ||||
Agency CMBS | — | (66,833) | (929) | (67,762) | ||||
CMBS IO | — | (389) | (652) | (1,041) | ||||
Other investments | — | 4 | — | 4 | ||||
Subtotal | (544) | (1,465,047) | (36,529) | (1,502,120) | ||||
TBA securities (1) | (38,823) | (86,079) | — | (124,902) | ||||
Net loss on investments | $(39,367) | $(1,551,126) | $(36,529) | $(1,627,022) | ||||
Interest rate hedging portfolio: | ||||||||
U.S. Treasury futures | $99,035 | $278,275 | $— | $377,310 | ||||
Interest rate swaps (2) | 7,692 | 782,825 | — | 790,517 | ||||
Interest rate swaptions | — | (2,581) | — | (2,581) | ||||
Options on U.S. Treasury futures | 743 | — | — | 743 | ||||
Net gain on interest rate hedges | $107,470 | $1,058,519 | $— | $1,165,989 | ||||
Total net gain (loss) | $68,103 | $(492,607) | $(36,529) | $(461,033) | ||||
Three Months Ended | ||||||||
June 30, 2026 | ||||||||
($s in thousands) | Realized Gain (Loss) Recognized in Net Income | Unrealized Gain (Loss) Recognized in Net Income | Unrealized Gain (Loss) Recognized in OCI | Total Change in Fair Value | ||||
Investment portfolio: | ||||||||
Agency RMBS | $— | $(17,336) | $(505) | $(17,841) | ||||
Agency CMBS | — | (8,208) | (24) | (8,232) | ||||
CMBS IO | — | (54) | (336) | (390) | ||||
Other investments | — | (24) | — | (24) | ||||
Subtotal | — | (25,622) | (865) | (26,487) | ||||
TBA securities (1) | (36,253) | 17,024 | — | (19,229) | ||||
Net loss on investments | $(36,253) | $(8,598) | $(865) | $(45,716) | ||||
Interest rate hedging portfolio: | ||||||||
U.S. Treasury futures | $112,723 | $(96,155) | $— | $16,568 | ||||
Interest rate swaps (2) | 606 | 135,175 | — | 135,781 | ||||
Interest rate swaptions | — | (4,275) | — | (4,275) | ||||
Options on U.S. Treasury futures | — | — | — | — | ||||
Net gain on interest rate hedges | $113,329 | $34,745 | $— | $148,074 | ||||
Total net gain (loss) | $77,076 | $26,147 | $(865) | $102,358 | ||||
Three Months Ended | ||||||||||||
September 30, 2026 | June 30, 2026 | |||||||||||
($s in thousands) | Implied Net Interest Income (1) | Average Balance | Implied Net Spread | Implied Net Interest Income (1) | Average Balance | Implied Net Spread | ||||||
TBAs | $8,394 | $2,393,855 | 1.37% | $5,221 | $1,879,681 | 1.10% | ||||||
(1)Implied net interest income (expense) is also referred to as “drop income (loss)” and represents a portion of the total realized gain (loss) from our TBA dollar roll transactions recorded within “gain (loss) on derivative instruments, net.” | ||||||||||||
Nine Months Ended | |||||||||||
September 30, | |||||||||||
2026 | 2025 | ||||||||||
($s in thousands) | Interest Income/ Expense | Average Balance (1)(2) | Effective Yield/ Financing Cost (3)(4) | Interest Income/ Expense | Average Balance (1)(2) | Effective Yield/ Financing Cost (3)(4) | |||||
Agency RMBS | $828,563 | $22,111,217 | 5.00% | $329,734 | 9,188,117 | 4.78% | |||||
Agency CMBS | 41,287 | 1,272,762 | 4.28% | 8,059 | 256,516 | 4.14% | |||||
CMBS IO (5) | 5,253 | 78,706 | 8.82% | 6,685 | 105,316 | 8.48% | |||||
Other investments | 17 | 445 | 3.84% | 42 | 926 | 4.37% | |||||
Subtotal | $875,120 | $23,463,130 | 4.97% | $344,520 | $9,550,875 | 4.81% | |||||
Cash equivalents | 17,517 | 11,964 | |||||||||
Total interest income | $892,637 | $356,484 | |||||||||
Repurchase agreement financing | (618,039) | 21,319,444 | (3.82)% | (285,612) | 8,407,509 | (4.48)% | |||||
Net interest income/ spread | $274,598 | 1.15% | $70,872 | 0.33% | |||||||
Net periodic interest (6) | 2,322 | 0.01% | 37,465 | 0.59% | |||||||
Economic net interest income/spread (6) | $276,920 | 1.16% | $108,337 | 0.92% | |||||||
*Table Note: Data may not foot due to rounding. | |||||||||||
Nine Months Ended | ||||||||
September 30, 2026 | ||||||||
($s in thousands)* | Realized Gain (Loss) Recognized in Net Income | Unrealized Gain (Loss) Recognized in Net Income | Unrealized Gain (Loss) Recognized in OCI | Total Change in Fair Value | ||||
Investment portfolio: | ||||||||
Agency RMBS | $7,917 | $(1,659,947) | $(35,676) | $(1,687,706) | ||||
Agency CMBS | 260 | (82,022) | (954) | (82,716) | ||||
CMBS IO | — | (489) | (912) | (1,401) | ||||
Other investments | — | (22) | — | (22) | ||||
Subtotal | 8,177 | (1,742,480) | (37,542) | (1,771,845) | ||||
TBA securities (1) | (72,854) | (85,157) | — | (158,011) | ||||
Net loss on investments | $(64,677) | $(1,827,637) | $(37,542) | $(1,929,856) | ||||
Interest rate hedging portfolio: | ||||||||
U.S. Treasury futures | $210,660 | $218,526 | $— | $429,186 | ||||
Interest rate swaps (2) | 9,629 | 1,002,959 | — | 1,012,587 | ||||
Interest rate swaptions | — | (7,190) | — | (7,190) | ||||
Options on U.S. Treasury futures | (3,239) | 1,325 | — | (1,914) | ||||
Net gain on interest rate hedges | $217,050 | $1,215,620 | $— | $1,432,669 | ||||
Total net gain (loss) | $152,373 | $(612,017) | $(37,542) | $(497,187) | ||||
*Table note: Data may not foot due to rounding. | ||||||||
Nine Months Ended | ||||||||
September 30, 2025 | ||||||||
($s in thousands)* | Realized Gain (Loss) Recognized in Net Income | Unrealized Gain (Loss) Recognized in Net Income | Unrealized Gain (Loss) Recognized in OCI | Total Change in Fair Value | ||||
Investment portfolio: | ||||||||
Agency RMBS | $— | $278,204 | $35,313 | $313,517 | ||||
Agency CMBS | — | 6,785 | 2,165 | 8,950 | ||||
CMBS IO | — | 1,148 | 942 | 2,090 | ||||
Other investments | — | (19) | — | (19) | ||||
Subtotal | — | 286,118 | 38,420 | 324,538 | ||||
TBA securities (1) | 52,422 | 24,932 | — | 77,354 | ||||
Net gain on investments | $52,422 | $311,050 | $38,420 | $401,892 | ||||
Interest rate hedging portfolio: | ||||||||
U.S. Treasury futures | $(29,129) | $(29,322) | $— | $(58,451) | ||||
Interest rate swaps | 37,465 | (242,450) | — | (204,985) | ||||
Interest rate swaptions | — | (286) | — | (286) | ||||
Options on U.S. Treasury futures | — | (508) | — | (508) | ||||
Net gain (loss) on interest rate hedges | $8,336 | $(272,566) | $— | $(264,230) | ||||
Total net gain | $60,758 | $38,484 | $38,420 | $137,662 | ||||
*Table note: Data may not foot due to rounding. | ||||||||
Nine Months Ended | ||||||||||||
September 30, | ||||||||||||
2026 | 2025 | |||||||||||
Implied Net Interest Income (1) | Average Balance | Implied Net Spread | Implied Net Interest Income (1) | Average Balance | Implied Net Spread | |||||||
TBAs | $18,378 | $2,091,903 | 1.16% | $13,091 | $2,496,558 | 0.69% | ||||||
Three Months Ended | ||||
Reconciliations of GAAP to Non-GAAP Financial Measures: | September 30, 2026 | June 30, 2026 | ||
($s in thousands except per share data) | ||||
Comprehensive (loss) income to common shareholders (GAAP) | $(374,834) | $177,278 | ||
Less: | ||||
Change in fair value of investments (1) | 1,502,120 | 26,487 | ||
Change in fair value of derivative instruments, net (2) | (1,032,611) | (123,082) | ||
EAD to common shareholders (non-GAAP) | $94,675 | $80,683 | ||
Average common shares outstanding | 251,842,414 | 222,220,145 | ||
EAD per common share (non-GAAP) | $0.38 | $0.36 | ||
Net interest income (GAAP) | $101,562 | $93,783 | ||
Net periodic interest earned from interest rate swaps | 82 | 542 | ||
Economic net interest income (non-GAAP) | 101,644 | 94,325 | ||
TBA drop income (3) | 8,394 | 5,221 | ||
Total operating expenses | (12,594) | (16,213) | ||
Preferred stock dividends | (2,769) | (2,650) | ||
EAD to common shareholders (non-GAAP) | $94,675 | $80,683 | ||
Net interest spread (GAAP) | 1.18% | 1.16% | ||
Net periodic interest from interest rate swaps as a percentage of average repurchase borrowings | —% | 0.01% | ||
Economic net interest spread (non-GAAP) | 1.18% | 1.17% | ||
Three Months Ended | |||
($s in thousands) | September 30, 2026 | June 30, 2026 | |
Gain on derivative instruments, net | $1,041,087 | 128,845 | |
Less: | |||
TBA drop income | (8,394) | (5,221) | |
Net periodic interest earned from interest rate swaps | (82) | (542) | |
Change in fair value of derivative instruments, net | $1,032,611 | $123,082 | |
Repurchase Agreements | |||||
($s in thousands) | Balance Outstanding As of Quarter End | Average Balance Outstanding For the Quarter Ended | Maximum Balance Outstanding During the Quarter Ended | ||
September 30, 2026 | $24,190,276 | $23,626,939 | $24,351,613 | ||
June 30, 2026 | 22,644,742 | 21,803,737 | 22,645,366 | ||
March 31, 2026 | 21,045,457 | 18,470,997 | 21,045,636 | ||
December 31, 2025 | 13,904,231 | 12,469,902 | 13,904,304 | ||
September 30, 2025 | 11,753,522 | 10,468,568 | 11,754,581 | ||
June 30, 2025 | 8,600,143 | 7,871,627 | 8,600,487 | ||
March 31, 2025 | 7,234,723 | 6,842,485 | 7,234,723 | ||
December 31, 2024 | 6,563,120 | 6,431,743 | 6,568,805 | ||
Nine Months Ended | ||||
September 30, | ||||
Cash received or paid by instrument: | 2026 | 2025 | ||
($s in thousands) | ||||
Interest rate swaps: | ||||
Net variation margin received (paid) | $958,001 | $(213,055) | ||
Received upon maturity/termination | 7,306 | — | ||
Net periodic interest received (1) | 11,647 | 18,659 | ||
976,954 | (194,396) | |||
U.S. Treasury futures: | ||||
Net variation margin received (paid) | 210,032 | (29,580) | ||
Received upon maturity/termination | 210,660 | (29,129) | ||
420,692 | (58,709) | |||
Options on U.S. Treasury futures | ||||
Premium paid at inception | (2,418) | (8,008) | ||
Received upon maturity/termination | 3,161 | — | ||
743 | (8,008) | |||
TBA securities: | ||||
(Paid) received upon settlement | (68,238) | 27,435 | ||
Net receipts (payments) on derivative instruments | $1,330,151 | $(233,678) | ||
Projected Period of Recognition for Tax Hedge Gains, Net | September 30, 2026 | |
($ in thousands) | ||
Fiscal year 2026 | $97,989 | |
Fiscal year 2027 | 96,449 | |
Fiscal year 2028 | 90,414 | |
Fiscal year 2029 | 91,733 | |
Fiscal year 2030 and thereafter | 249,014 | |
$625,599 |
September 30, 2026 | ||||||||||||||||
Parallel Decrease in Interest Rates of | Parallel Increase in Interest Rates of | |||||||||||||||
100 Basis Points | 50 Basis Points | 50 Basis Points | 100 Basis Points | |||||||||||||
Type of Instrument (1) | % of Market Value | % of Common Equity | % of Market Value | % of Common Equity | % of Market Value | % of Common Equity | % of Market Value | % of Common Equity | ||||||||
RMBS | 4.8% | 47.9% | 2.5% | 24.8% | (2.6)% | (25.6)% | (5.1)% | (51.4)% | ||||||||
CMBS/CMBS IO | 0.3% | 2.6% | 0.1% | 1.3% | (0.1)% | (1.2)% | (0.2)% | (2.4)% | ||||||||
TBAs | 0.5% | 4.6% | 0.2% | 2.4% | (0.3)% | (2.6)% | (0.5)% | (5.2)% | ||||||||
Interest rate hedges | (5.8)% | (58.3)% | (2.9)% | (28.9)% | 2.9% | 28.9% | 5.7% | 57.3% | ||||||||
Total | (0.2)% | (3.2)% | (0.1)% | (0.4)% | (0.1)% | (0.5)% | (0.1)% | (1.7)% | ||||||||
December 31, 2025 | ||||||||||||||||
Parallel Decrease in Interest Rates of | Parallel Increase in Interest Rates of | |||||||||||||||
100 Basis Points | 50 Basis Points | 50 Basis Points | 100 Basis Points | |||||||||||||
Type of Instrument (1) | % of Market Value | % of Common Equity | % of Market Value | % of Common Equity | % of Market Value | % of Common Equity | % of Market Value | % of Common Equity | ||||||||
RMBS | 2.3% | 19.1% | 1.4% | 11.6% | (1.8)% | (15.1)% | (3.9)% | (32.3)% | ||||||||
CMBS/CMBS IO | 0.3% | 2.4% | 0.1% | 1.2% | (0.1)% | (1.1)% | (0.3)% | (2.3)% | ||||||||
TBAs | 0.7% | 5.6% | 0.4% | 3.2% | (0.4)% | (3.7)% | (0.9)% | (7.6)% | ||||||||
Interest rate hedges | (4.4)% | (36.7)% | (2.2)% | (18.2)% | 2.2% | 17.8% | 4.3% | 35.7% | ||||||||
Total | (1.1)% | (9.6)% | (0.3)% | (2.2)% | (0.1)% | (2.1)% | (0.8)% | (6.5)% | ||||||||
September 30, 2026 | December 31, 2025 | |||||||||||
Non-Parallel Shifts | Basis Point Change in 2-year UST | Basis Point Change in 10-year UST | % of Market Value (1) | % of Common Equity | % of Market Value (1) | % of Common Equity | ||||||
Bearish | Steepening | +25 | +50 | —% | (0.2)% | (0.2)% | (1.4)% | |||||
+50 | +100 | (0.1)% | (1.3)% | (0.6)% | (5.3)% | |||||||
Flattening | +50 | +25 | (0.1)% | (0.6)% | (0.2)% | (1.4)% | ||||||
+100 | +50 | (0.1)% | (1.2)% | (0.4)% | (3.4)% | |||||||
Bullish | Steepening | -50 | -25 | —% | 0.4% | —% | —% | |||||
-100 | -50 | 0.1% | 0.5% | (0.2)% | (1.7)% | |||||||
Flattening | -25 | -50 | (0.1)% | (0.8)% | (0.3)% | (2.8)% | ||||||
-50 | -100 | (0.5)% | (4.5)% | (1.3)% | (10.6)% | |||||||
September 30, 2026 | December 31, 2025 | |||||||
Percentage Change in | Percentage Change in | |||||||
Basis Point Change in Market Spreads | Market Value of Investments (1) | % of Common Equity | Market Value of Investments (1) | % of Common Equity | ||||
‘+20 | (1.1)% | (11.5)% | (1.0)% | (8.4)% | ||||
‘+10 | (0.6)% | (5.7)% | (0.5)% | (4.2)% | ||||
‘-10 | 0.6% | 5.7% | 0.5% | 4.2% | ||||
‘-20 | 1.1% | 11.5% | 1.0% | 8.4% | ||||
Exhibit No. | Description |
3.1 | Restated Articles of Incorporation, effective May 14, 2021 (incorporated herein by reference to Exhibit 3.1 to Dynex's Current Report on Form 8-K filed May 18, 2021). |
3.1.1 | Second Articles of Amendment to the Restated Articles of Incorporation, effective as of May 21, 2025 (incorporated herein by reference to Exhibit 3.1.1 to Dynex’s Current Report on Form 8-K filed May 21, 2025). |
3.1.2 | Third Articles of Amendment to the Restated Articles of Incorporation, effective as of May 22, 2026 (incorporated herein by reference to Exhibit 3.1 to Dynex’s Current Report on Form 8-K filed May 22, 2026). |
Exhibit No. | Description |
3.1.3 | Articles of Amendment to the Restated Articles of Incorporation, effective September 29, 2026 (incorporated herein by reference to Exhibit 3.4 to Dynex’s Registration Statement on Form 8-A12B filed September 29, 2026). |
3.2 | Amended and Restated Bylaws, effective as of May 11, 2021 (incorporated herein by reference to Exhibit 3.2 to Dynex’s Current Report on Form 8-K filed May 12, 2021). |
4.1 | Specimen of Common Stock Certificate (incorporated herein by reference to Exhibit 4.1 to Dynex's Quarterly Report on Form 10-Q for the quarter ended September 30, 2019). |
4.2 | Specimen of 6.900% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock Certificate (incorporated herein by reference to Exhibit 4.4 to Dynex's Registration Statement on Form 8-A12B filed February 18, 2020). |
4.3 | Specimen of 9.375% Series D Fixed-Rate Cumulative Redeemable Preferred Stock Certificate (incorporated herein by reference to Exhibit 4.3 Dynex’s Registration Statement on Form 8-A12B filed September 29, 2026). |
10.1 | Amendment No. 10, dated July 28, 2026 to the Distribution Agreement, dated June 29, 2018, as amended on May 31, 2019, August 3, 2021, June 3, 2022, February 10, 2023, October 29, 2024, May 1, 2025, July 29, 2025, January 27, 2026, and April 28, 2026 by and among Dynex Capital, Inc., BTIG, LLC, Citizens JMP Securities, LLC, Goldman Sachs & Co. LLC, JonesTrading Institutional Services LLC, J.P. Morgan Securities LLC, Keefe, Bruyette & Woods, Inc., Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, UBS Securities LLC, and Wells Fargo Securities, LLC (incorporated herein by reference to Exhibit 10.1 to Dynex’ Current Report on Form 8-K filed July 28, 2026). |
31.1 | Certification of co-principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith). |
31.2 | Certification of co-principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith). |
31.3 | Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith). |
32.1 | Certification of co-principal executive officers and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith). |
101 | The following materials from Dynex Capital, Inc.'s Quarterly Report on Form 10-Q for the three months ended September 30, 2026, formatted in iXBRL (Inline Extensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Statements of Shareholders’ Equity, (iv) Consolidated Statements of Cash Flows, and (v) Notes to the Unaudited Consolidated Financial Statements. |
104 | The cover page from Dynex Capital, Inc.'s Quarterly Report on Form 10-Q for the three months ended September 30, 2026, formatted in iXBRL (Inline Extensible Business Reporting Language) (included with Exhibit 101). |
DYNEX CAPITAL, INC. | |||
Date: | October 27, 2026 | /s/ Michael A. Sartori | |
Michael A. Sartori | |||
Chief Financial Officer | |||
(Principal Financial Officer) | |||